Cargando…

Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin

Detalles Bibliográficos
Autores principales:	Buta, Corina, Benabou, Eva, Lequoy, Marie, Régnault, Hélène, Wendum, Dominique, Merabtene, Fatiha, Chettouh, Hamza, Aoudjehane, Lynda, Conti, Filomena, Chrétien, Yves, Scatton, Olivier, Rosmorduc, Olivier, Praz, Françoise, Fartoux, Laetitia, Desbois-Mouthon, Christèle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5039828/ https://www.ncbi.nlm.nih.gov/pubmed/27680564 http://dx.doi.org/10.1186/s13046-016-0438-4

Ejemplares similares

Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
por: Buta, Corina, et al.
Publicado: (2016)

Cold-Atmospheric Plasma Induces Tumor Cell Death in Preclinical In Vivo and In Vitro Models of Human Cholangiocarcinoma
por: Vaquero, Javier, et al.
Publicado: (2020)

Ex-Vivo Pharmacological Defatting of the Liver: A Review
por: Goumard, Claire, et al.
Publicado: (2021)

Regulation of the EGFR/ErbB signalling by clathrin in response to various ligands in hepatocellular carcinoma cell lines
por: Liu, Yuanhui, et al.
Publicado: (2020)

Diet‐Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice
por: Debray, Dominique, et al.
Publicado: (2018)

Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosis
por: Aoudjehane, Lynda, et al.
Publicado: (2020)

Scattering of MCF7 Cells by Heregulin ß-1 Depends on the MEK and p38 MAP Kinase Pathway
por: Okoshi, Rintaro, et al.
Publicado: (2013)

Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C
por: Aoudjehane, Lynda, et al.
Publicado: (2015)

The beta secretase BACE1 regulates the expression of insulin receptor in the liver
por: Meakin, Paul J., et al.
Publicado: (2018)

LCR1 and LCR2, two multi‐analyte blood tests to assess liver cancer risk in patients without or with cirrhosis
por: Poynard, Thierry, et al.
Publicado: (2018)

Hepatitis C Virus Improves Human Tregs Suppressive Function and Promotes Their Recruitment to the Liver
por: Ouaguia, Laurissa, et al.
Publicado: (2019)

γ-Heregulin has no biological significance in primary breast cancer
por: Sánchez-Valdivieso, E A, et al.
Publicado: (2002)

Heregulin, a new regulator of telomere length in human cells
por: Menendez, Javier A., et al.
Publicado: (2015)

Heregulin Activity Assays for Residual Testing of Cell Therapy Products
por: Monje, Paula V., et al.
Publicado: (2021)

CD49b, a Major Marker of Regulatory T-Cells Type 1, Predicts the Response to Antiviral Therapy of Recurrent Hepatitis C after Liver Transplantation
por: Fabien, Stenard, et al.
Publicado: (2014)

An Efficient 5-Aminolevulinic Acid Photodynamic Therapy Treatment for Human Hepatocellular Carcinoma
por: Kumar, Abhishek, et al.
Publicado: (2023)

Localization of phosphorylated ErbB1-4 and heregulin in colorectal cancer
por: Mitsui, Keigo, et al.
Publicado: (2014)

Heregulin, a new interactor of the telosome/shelterin complex in human telomeres
por: Menendez, Javier A., et al.
Publicado: (2015)

Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene
por: Rosmorduc, Olivier, et al.
Publicado: (2007)

Regression of Hypervascular Nodules in a Patient with Wilson's Disease Awaiting Liver Transplantation
por: Pissaia, Alcindo, et al.
Publicado: (2009)

Impact of the first Covid-19 outbreak on liver transplantation activity in France: A snapshot
por: Turco, Célia, et al.
Publicado: (2021)

Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer
por: Yonesaka, Kimio, et al.
Publicado: (2015)

ADAM10-mediated release of heregulin confers resistance to trastuzumab by activating HER3
por: Ebbing, Eva A., et al.
Publicado: (2016)

Metabolic Optimisation of Regulatory T Cells in Transplantation
por: Atif, Mo, et al.
Publicado: (2020)

Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells
por: Kang, Jeffrey C, et al.
Publicado: (2014)

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer
por: Mota, Jose Mauricio, et al.
Publicado: (2017)

Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer
por: Papadimitropoulou, Adriana, et al.
Publicado: (2020)

Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany
por: Huebner, Hanna, et al.
Publicado: (2020)

Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study
por: André, T, et al.
Publicado: (2008)

The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells
por: Kawakami, Hisato, et al.
Publicado: (2014)

Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin
por: Yoo, J-Y, et al.
Publicado: (2000)

Expression of HER3, HER4 and their ligand heregulin-4 is associated with better survival in bladder cancer patients
por: Memon, A A, et al.
Publicado: (2004)

A feed-forward loop between SorLA and HER3 determines heregulin response and neratinib resistance
por: Al-Akhrass, Hussein, et al.
Publicado: (2021)

The impact of Coronavirus 19 disease on liver transplantation in France: The sickest first approach?
por: Mazzola, Alessandra, et al.
Publicado: (2020)

COVID-19 in a liver transplant recipient: Could iatrogenic immunosuppression have prevented severe pneumonia? A case report
por: Sessa, Anna, et al.
Publicado: (2020)

Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells
por: Hutcheson, Iain R, et al.
Publicado: (2007)

Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1
por: Hiscox, S, et al.
Publicado: (2008)

ErbB3 Ligand Heregulin1 Is a Major Mitogenic Factor for Uncontrolled Lung Cancer Cell Proliferation()()
por: Ma, Shiqi, et al.
Publicado: (2019)

Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer
por: Menendez, Javier A., et al.
Publicado: (2020)

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer
por: Steele, Thomas M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0atbjict55l4ag306d8j9jd0dv